HEMAY PHARMA-B (00054.HK): Postpones HK IPO, Application Monies Refunded

NewTimeSpace News: Ganzhou Hemay Pharmaceutical Co., Ltd. (stock code: 00054) announced that, given the current market conditions, it has decided to postpone the global offering and the listing. The International Underwriting Agreement will not be entered into and the Hong Kong Underwriting Agreement will therefore not become unconditional. The Company said it remains committed to completing the global offering and the listing in due course.

Application monies paid through the HK eIPO White Form service, including brokerage of 1.0%, SFC transaction levy of 0.0027%, AFRC transaction levy of 0.00015% and Stock Exchange trading fee of 0.00565%, will be refunded in full without interest. For monies paid from a single bank account, e-Auto Refund instructions will be despatched to the relevant payment bank accounts on 9 November 2026; for monies paid from multiple bank accounts, refund cheques will be sent by ordinary post on the same date at the applicants' own risk.

As at the date of the announcement, no H share certificates have been issued and none will be delivered to any applicant.